DPP4 and myocardial infarction: Sitagliptin was found to improve passive left ventricular compliance, increase endothelial cell density, reduce myocyte hypertrophy, and decrease collagen 1 abundance in an in vivo study involving diabetic rats following MI [171], suggesting that DPP-4 inhibitors may attenuate aspects of cardiac dysfunction and adverse remodeling after MI.